Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Kimberly Meade-White
Affiliation
National Institutes of Allergy and Infectious Disease, National Institutes of Health
ORCID
Career Start Year
2002
Papers
87
H Index
33
Expertise
CM4AI Collaborator
Nevan J Krogan (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36184852
Accelerated DNA vaccine regimen provides protection against Crimean-Congo hemorrhagic fever virus challenge in a macaque model.
Mol Ther
2023
37866114
CD8<sup>+</sup> T-cells target the Crimean-Congo haemorrhagic fever virus Gc protein to control the infection in wild-type mice.
EBioMedicine
2023
37756057
Histopathologic Characterization of Experimental Peracute SARS-CoV-2 Infection in the Syrian Hamster.
Vet Sci
2023
37611878
Favipiravir and Ribavirin protect immunocompetent mice from lethal CCHFV infection.
Antiviral Res
2023
37731485
Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease.
Front Immunol
2023
37075079
A replicon RNA vaccine can induce durable protective immunity from SARS-CoV-2 in nonhuman primates after neutralizing antibodies have waned.
PLoS Pathog
2023
37235549
Immunocompetent hamsters as a model for orthobunyavirus-induced neuroinvasion and neuropathology.
PLoS Negl Trop Dis
2023
36508878
Distinct VSV-based Nipah virus vaccines expressing either glycoprotein G or fusion protein F provide homologous and heterologous protection in a nonhuman primate model.
EBioMedicine
2023
35233571
Molnupiravir (MK-4482) is efficacious against Omicron and other SARS-CoV-2 variants in the Syrian hamster COVID-19 model.
bioRxiv
2022
35579953
Molnupiravir inhibits SARS-CoV-2 variants including Omicron in the hamster model.
JCI Insight
2022
35860599
Development of a nonhuman primate model for mammalian bornavirus infection.
PNAS Nexus
2022
36399566
SARS-CoV-2 Omicron BA.1 and BA.2 are attenuated in rhesus macaques as compared to Delta.
Sci Adv
2022
35971544
SARS-CoV-2 Omicron BA.1 and BA.2 are attenuated in rhesus macaques as compared to Delta.
bioRxiv
2022
35907368
Replicating RNA vaccination elicits an unexpected immune response that efficiently protects mice against lethal Crimean-Congo hemorrhagic fever virus challenge.
EBioMedicine
2022
35932641
Replicating RNA platform enables rapid response to the SARS-CoV-2 Omicron variant and elicits enhanced protection in naïve hamsters compared to ancestral vaccine.
EBioMedicine
2022
35982677
A replicon RNA vaccine induces durable protective immunity from SARS-CoV-2 in nonhuman primates after neutralizing antibodies have waned.
bioRxiv
2022
35191378
SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
Elife
2022
35263638
SARS-CoV-2 reinfection prevents acute respiratory disease in Syrian hamsters but not replication in the upper respiratory tract.
Cell Rep
2022
33469217
Publisher Correction: ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques.
Nature
2021
33654106
ChAdOx1-vectored Lassa fever vaccine elicits a robust cellular and humoral immune response and protects guinea pigs against lethal Lassa virus challenge.
NPJ Vaccines
2021
33572859
T-Cells and Interferon Gamma Are Necessary for Survival Following Crimean-Congo Hemorrhagic Fever Virus Infection in Mice.
Microorganisms
2021
33821272
Recovery from acute SARS-CoV-2 infection and development of anamnestic immune responses in T cell-depleted rhesus macaques.
bioRxiv
2021
33922222
<i>Mastomys natalensis</i> Has a Cellular Immune Response Profile Distinct from Laboratory Mice.
Viruses
2021
33754147
A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques.
Cell Rep Med
2021
33532770
A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques.
bioRxiv
2021
33863887
Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model.
Nat Commun
2021
33886507
Intradermal delivery of a synthetic DNA vaccine protects macaques from Middle East respiratory syndrome coronavirus.
JCI Insight
2021
33831142
Broadly neutralizing monoclonal antibodies protect against multiple tick-borne flaviviruses.
J Exp Med
2021
34907224
A live-attenuated viral vector vaccine protects mice against lethal challenge with Kyasanur Forest disease virus.
NPJ Vaccines
2021
34931189
SARS-CoV2 variant-specific replicating RNA vaccines protect from disease and pathology and reduce viral shedding following challenge with heterologous SARS-CoV2 variants of concern.
bioRxiv
2021
34724885
UK B.1.1.7 (Alpha) variant exhibits increased respiratory replication and shedding in nonhuman primates.
Emerg Microbes Infect
2021
34159332
UK B.1.1.7 variant exhibits increased respiratory replication and shedding in nonhuman primates.
bioRxiv
2021
34072112
Continuing Orthohantavirus Circulation in Deer Mice in Western Montana.
Viruses
2021
34013879
Ebola Virus IgG Seroprevalence in Southern Mali.
Emerg Infect Dis
2021
34013842
Alkhurma haemorrhagic fever virus causes lethal disease in IFNAR<sup>-/-</sup> mice.
Emerg Microbes Infect
2021
34311582
Recovery from Acute SARS-CoV-2 Infection and Development of Anamnestic Immune Responses in T Cell-Depleted Rhesus Macaques.
mBio
2021
33431511
Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in lungs of African green monkeys.
Sci Transl Med
2021
33416494
Immunocompetent mouse model for Crimean-Congo hemorrhagic fever virus.
Elife
2021
32511299
Respiratory disease and virus shedding in rhesus macaques inoculated with SARS-CoV-2.
bioRxiv
2020
31934358
A single dose of a vesicular stomatitis virus-based influenza vaccine confers rapid protection against H5 viruses from different clades.
NPJ Vaccines
2020
31682727
Rousettus aegyptiacus Bats Do Not Support Productive Nipah Virus Replication.
J Infect Dis
2020
33251966
Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection.
Emerg Microbes Infect
2020
33052329
Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model.
Res Sq
2020
33090972
Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models.
JCI Insight
2020
32577633
Hydroxychloroquine Proves Ineffective in Hamsters and Macaques Infected with SARS-CoV-2.
bioRxiv
2020
32577525
A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques.
Sci Adv
2020
32995767
Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection.
bioRxiv
2020
32731258
ChAdOx1Â nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques.
Nature
2020
32645335
Efficacy of favipiravir (T-705) against Crimean-Congo hemorrhagic fever virus infection in cynomolgus macaques.
Antiviral Res
2020
32641828
Envelope protein ubiquitination drives entry and pathogenesis of Zika virus.
Nature
2020
1 - 50 of 87
Column Actions
Search
Recommended Authors
James Logue
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year
2017
Number of shared co-authors
4
Kathleen M Voss
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year
2016
Number of shared co-authors
1
Sarah R Leist
University of North Carolina at Chapel Hill
Career Start Year
2014
Number of shared co-authors
3
Nicholas Dambrauskas
Center for Global Infectious Disease Research, Seattle Children's Research Institute
Career Start Year
2013
Number of shared co-authors
0
Natalia A Kuzmina
University of Texas Medical Branch, USA Galveston National Laboratory
Career Start Year
2012
Number of shared co-authors
1
Kenneth S Plante
University of Texas Medical Branch
Career Start Year
2009
Number of shared co-authors
8
Vineet D Menachery
University of Texas Medical Branch
Career Start Year
2008
Number of shared co-authors
10
Alexander N Freiberg
University of Texas Medical Branch
Career Start Year
2008
Number of shared co-authors
15
Stephanie A Montgomery
and Lineberger Comprehensive Cancer Center, University of North Carolina System
Career Start Year
2006
Number of shared co-authors
2
Sudhakar Agnihothram
National Center for Toxicological Research
Career Start Year
2005
Number of shared co-authors
3
Claudia T Flynn
The Scripps Research Institute
Career Start Year
2004
Number of shared co-authors
1
Sunil Thomas
Lankenau Institute for Medical Research
Career Start Year
2004
Number of shared co-authors
2
Alexandra Sch??fer
University of North Carolina at Chapel Hill
Career Start Year
2003
Number of shared co-authors
5
Kayvon Modjarrad
Center for Infectious Diseases Research, Walter Reed Army Institute of Research
Career Start Year
2002
Number of shared co-authors
4
Lisa E Gralinski
University of North Carolina at Chapel Hill
Career Start Year
2002
Number of shared co-authors
4
Thomas E Morrison
University of Colorado Anschutz Medical Campus
Career Start Year
2001
Number of shared co-authors
1
Luis Martinez-Sobrido
Texas Biomedical Research Institute
Career Start Year
2001
Number of shared co-authors
6
Larissa B Thackray
Washington University School of Medicine
Career Start Year
1996
Number of shared co-authors
4
Theodora Hatziioannou
The Rockefeller University
Career Start Year
1995
Number of shared co-authors
0
Matthew B Frieman
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year
1993
Number of shared co-authors
5
Boyd L Yount
University of North Carolina at Chapel Hill
Career Start Year
1993
Number of shared co-authors
4
Ande West
University of North Carolina at Chapel Hill
Career Start Year
1993
Number of shared co-authors
0
James E Strong
University of Manitoba
Career Start Year
1991
Number of shared co-authors
6
Chien-Te K Tseng
The University of Texas Medical Branch
Career Start Year
1991
Number of shared co-authors
2
Mark T Heise
University of North Carolina at Chapel Hill.
Career Start Year
1990
Number of shared co-authors
5
Juergen A Richt
College of Veterinary Medicine, Kansas State University
Career Start Year
1988
Number of shared co-authors
4
Bart L Haagmans
Erasmus Medical Center
Career Start Year
1986
Number of shared co-authors
3
Ralph S Baric
University of North Carolina
Career Start Year
1981
Number of shared co-authors
8
Robert F Garry
Tulane University School of Medicine
Career Start Year
1974
Number of shared co-authors
3
Clarence J Peters
University of Texas Medical Branch at Galveston
Career Start Year
1970
Number of shared co-authors
1
row(s) 1 - 30 of 30
Collaborators
Emmie de Wit
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers
14
Deepashri Rao
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers
6
Michael S Diamond
Washington University School of Medicine
Co-authored papers
3
Sonja M Best
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers
3
Kim J Hasenkrug
National Institute of Allergy and Infectious Diseases
Co-authored papers
3
Michael Gale
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers
3
Mario L Santiago
Co-authored papers
2
Sarah L Anzick
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers
2
Gail L Sturdevant
National Institute of Allergy and Infectious Diseases
Co-authored papers
2
David B Weiner
Wistar Institute
Co-authored papers
2
Elizabeth R Fischer
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers
2
Ronald J Messer
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers
2
Eliezer Masliah
National Institute On Aging
Co-authored papers
2
Shelly J Robertson
National Institute of Allergy and Infectious Diseases
Co-authored papers
1
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers
1
Sarah Sebastian
Co-authored papers
1
Michael Woodson
University of Texas Medical Branch, 301 University Boulevard
Co-authored papers
1
Gary P Kobinger
University of Texas Medical Branch
Co-authored papers
1
Sarah van Tol
University of Texas Medical Branch
Co-authored papers
1
Jeffrey R Johnson
Gladstone Institutes
Co-authored papers
1
Maria I Giraldo
University of Texas Medical Branch
Co-authored papers
1
Kristin L McNally
National Institute of Allergy and Infectious Diseases
Co-authored papers
1
Holly Ramage
Sidney Kimmel Medical College, Thomas Jefferson University
Co-authored papers
1
Adam Hage
University of Texas Medical Branch
Co-authored papers
1
Wendy Maury
Carver College of Medicine, University of Iowa
Co-authored papers
1
Laura A VanBlargan
Washington University School of Medicine
Co-authored papers
1
Marc C Morais
University of Texas Medical Branch
Co-authored papers
1
Hongjie Xia
University of Texas Medical Branch
Co-authored papers
1
Chao Shan
Wuhan Institute of Virology, Chinese Academy of Sciences
Co-authored papers
1
Michael L Gross
Washington University in St. Louis
Co-authored papers
1
1 - 30